• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由信号转导和转录激活因子4(STAT4)调控的脯氨酸富积酸性蛋白1(PSAT1)通过磷脂酰肌醇-3激酶/蛋白激酶B(PI3K/AKT)途径增强卵巢癌细胞的增殖、侵袭和迁移能力。

PSAT1 regulated by STAT4 enhances the proliferation, invasion and migration of ovarian cancer cells via the PI3K/AKT pathway.

作者信息

Li Xiao, Wang Shuang, Nie Xin, Hu Yuexin, Liu Ouxuan, Wang Yuxuan, Lin Bei

机构信息

Department of Gynecology and Obstetrics, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, P.R. China.

Department of Obstetrics and Gynaecology, Tianjin Central Hospital of Gynecology Obstetrics, Tianjin 300277, P.R. China.

出版信息

Int J Mol Med. 2025 Jun;55(6). doi: 10.3892/ijmm.2025.5529. Epub 2025 Apr 11.

DOI:10.3892/ijmm.2025.5529
PMID:40211693
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12005366/
Abstract

Epithelial ovarian cancer, the most prevalent form of ovarian cancer, is a health concern worldwide. Phosphoserine aminotransferase 1 (PSAT1), as the rate‑limiting enzyme in serine synthesis, is key in the conversion of 3‑phosphoglycerate to serine. The present study explored the role of PSAT1 expression in epithelial ovarian tumors. Gene Expression Profiling Interactive Analysis was used for gene expression and survival analyses. The effects of PSAT1 overexpression and knockdown on invasion, migration, proliferation and cell cycle progression of ovarian cancer cell lines were investigated both and . Western blotting was conducted to assess alterations in PI3K/AKT signalling pathway proteins. Database and tissue sample data confirmed that PSAT1 was significantly upregulated in ovarian cancer. Preliminary functional investigations indicated that PSAT1 was involved in modulation of invasion and migration, demonstrating the capacity of PSAT1 to enhance expression of the PI3K/AKT signalling pathway. These findings suggested that PSAT1 served a critical role in the onset and progression of ovarian cancer, thereby offering a theoretical basis for early detection and therapeutic strategies.

摘要

上皮性卵巢癌是卵巢癌最常见的形式,是全球关注的健康问题。磷酸丝氨酸转氨酶1(PSAT1)作为丝氨酸合成中的限速酶,在3-磷酸甘油酸转化为丝氨酸的过程中起关键作用。本研究探讨了PSAT1表达在上皮性卵巢肿瘤中的作用。利用基因表达谱交互分析进行基因表达和生存分析。通过体内和体外实验研究了PSAT1过表达和敲低对卵巢癌细胞系侵袭、迁移、增殖和细胞周期进程的影响。进行蛋白质免疫印迹法以评估PI3K/AKT信号通路蛋白的变化。数据库和组织样本数据证实PSAT1在卵巢癌中显著上调。初步功能研究表明,PSAT1参与侵袭和迁移的调节,表明PSAT1具有增强PI3K/AKT信号通路表达的能力。这些发现提示PSAT1在卵巢癌的发生和发展中起关键作用,从而为早期检测和治疗策略提供理论依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2da0/12005366/b75d1ca4921d/ijmm-55-06-05529-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2da0/12005366/b3270e0fb5d3/ijmm-55-06-05529-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2da0/12005366/2d8e776dda75/ijmm-55-06-05529-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2da0/12005366/c9d1763822fb/ijmm-55-06-05529-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2da0/12005366/e9d0e641a685/ijmm-55-06-05529-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2da0/12005366/bffbbc59bf98/ijmm-55-06-05529-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2da0/12005366/b75d1ca4921d/ijmm-55-06-05529-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2da0/12005366/b3270e0fb5d3/ijmm-55-06-05529-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2da0/12005366/2d8e776dda75/ijmm-55-06-05529-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2da0/12005366/c9d1763822fb/ijmm-55-06-05529-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2da0/12005366/e9d0e641a685/ijmm-55-06-05529-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2da0/12005366/bffbbc59bf98/ijmm-55-06-05529-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2da0/12005366/b75d1ca4921d/ijmm-55-06-05529-g05.jpg

相似文献

1
PSAT1 regulated by STAT4 enhances the proliferation, invasion and migration of ovarian cancer cells via the PI3K/AKT pathway.由信号转导和转录激活因子4(STAT4)调控的脯氨酸富积酸性蛋白1(PSAT1)通过磷脂酰肌醇-3激酶/蛋白激酶B(PI3K/AKT)途径增强卵巢癌细胞的增殖、侵袭和迁移能力。
Int J Mol Med. 2025 Jun;55(6). doi: 10.3892/ijmm.2025.5529. Epub 2025 Apr 11.
2
PSAT1 Upregulation Contributes to Cell Growth and Cisplatin Resistance in Cervical Cancer Cells via Regulating PI3K/AKT Signaling Pathway.PSAT1 上调通过调节 PI3K/AKT 信号通路促进宫颈癌细胞的生长和顺铂耐药性。
Ann Clin Lab Sci. 2020 Jul;50(4):512-518.
3
Upregulated microRNA-15b alleviates ovarian cancer through inhitbition of the PI3K/Akt pathway by targeting LPAR3.上调 microRNA-15b 通过靶向 LPAR3 抑制 PI3K/Akt 通路缓解卵巢癌。
J Cell Physiol. 2019 Dec;234(12):22331-22342. doi: 10.1002/jcp.28799. Epub 2019 May 29.
4
Selective loss of phosphoserine aminotransferase 1 (PSAT1) suppresses migration, invasion, and experimental metastasis in triple negative breast cancer.磷酸丝氨酸转氨酶 1(PSAT1)选择性缺失抑制三阴性乳腺癌的迁移、侵袭和实验性转移。
Clin Exp Metastasis. 2020 Feb;37(1):187-197. doi: 10.1007/s10585-019-10000-7. Epub 2019 Oct 19.
5
Overexpression of Long Noncoding RNA H19 Downregulates miR-140-5p and Activates PI3K/AKT Signaling Pathway to Promote Invasion, Migration and Epithelial-Mesenchymal Transition of Ovarian Cancer Cells.长链非编码 RNA H19 的过表达下调 miR-140-5p 并激活 PI3K/AKT 信号通路,促进卵巢癌细胞的侵袭、迁移和上皮-间充质转化。
Biomed Res Int. 2021 Jun 21;2021:6619730. doi: 10.1155/2021/6619730. eCollection 2021.
6
SRC-3/TRAF4 facilitates ovarian cancer development by activating the PI3K/AKT signaling pathway.SRC-3/TRAF4 通过激活 PI3K/AKT 信号通路促进卵巢癌的发展。
Med Oncol. 2023 Jan 10;40(2):76. doi: 10.1007/s12032-022-01944-0.
7
HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.HPIP通过激活PI3K/AKT信号通路促进卵巢癌细胞上皮-间质转化和顺铂耐药。
Cell Oncol (Dordr). 2017 Apr;40(2):133-144. doi: 10.1007/s13402-016-0308-2. Epub 2016 Dec 30.
8
Long noncoding RNA-JPX predicts the poor prognosis of ovarian cancer patients and promotes tumor cell proliferation, invasion and migration by the PI3K/Akt/mTOR signaling pathway.长链非编码 RNA-JPX 可预测卵巢癌患者的不良预后,并通过 PI3K/Akt/mTOR 信号通路促进肿瘤细胞增殖、侵袭和迁移。
Eur Rev Med Pharmacol Sci. 2018 Dec;22(23):8135-8144. doi: 10.26355/eurrev_201812_16505.
9
Keratinocyte differentiation factor 1 enhances cervical cancer cell viability and migration by activating the PI3K/AKT pathway.角质细胞分化因子 1 通过激活 PI3K/AKT 通路增强宫颈癌癌细胞活力和迁移。
J Obstet Gynaecol. 2024 Dec;44(1):2362420. doi: 10.1080/01443615.2024.2362420. Epub 2024 Jun 12.
10
MiR-198 inhibits proliferation, invasion and migration of ovarian cancer cells by regulating the PI3K/Akt signaling pathway.miR-198 通过调控 PI3K/Akt 信号通路抑制卵巢癌细胞的增殖、侵袭和迁移。
Acta Biochim Pol. 2021 Jun 28;68(4):673-677. doi: 10.18388/abp.2020_5546.

本文引用的文献

1
Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets.肿瘤起始与早期癌变:分子机制与干预靶点。
Signal Transduct Target Ther. 2024 Jun 19;9(1):149. doi: 10.1038/s41392-024-01848-7.
2
PSAT1 mediated EMT of colorectal cancer cells by regulating Pl3K/AKT signaling pathway.PSAT1通过调节PI3K/AKT信号通路介导结肠癌细胞的上皮-间质转化。
J Cancer. 2024 Apr 15;15(10):3183-3198. doi: 10.7150/jca.93789. eCollection 2024.
3
Overexpression of PSAT1 is Correlated with Poor Prognosis and Immune Infiltration in Non-Small Cell Lung Cancer.
PSAT1 过表达与非小细胞肺癌的不良预后和免疫浸润相关。
Front Biosci (Landmark Ed). 2023 Oct 19;28(10):243. doi: 10.31083/j.fbl2810243.
4
PSAT1 positively regulates the osteogenic lineage differentiation of periodontal ligament stem cells through the ATF4/PSAT1/Akt/GSK3β/β-catenin axis.PSAT1 通过 ATF4/PSAT1/Akt/GSK3β/β-catenin 轴正向调控牙周膜干细胞的成骨谱系分化。
J Transl Med. 2023 Feb 2;21(1):70. doi: 10.1186/s12967-022-03775-z.
5
miRNA-195-5p/PSAT1 feedback loop in human triple-negative breast cancer cells.人三阴性乳腺癌细胞中的miRNA-195-5p/PSAT1反馈环
Genes Genomics. 2023 Jan;45(1):39-47. doi: 10.1007/s13258-022-01327-9. Epub 2022 Nov 12.
6
Metabolic and Nonmetabolic Functions of PSAT1 Coordinate Signaling Cascades to Confer EGFR Inhibitor Resistance and Drive Progression in Lung Adenocarcinoma.PSAT1 的代谢和非代谢功能协调信号级联反应,赋予表皮生长因子受体抑制剂耐药性,并推动肺腺癌的进展。
Cancer Res. 2022 Oct 4;82(19):3516-3531. doi: 10.1158/0008-5472.CAN-21-4074.
7
PI3K/Akt/mTOR Pathway and Its Role in Cancer Therapeutics: Are We Making Headway?PI3K/Akt/mTOR信号通路及其在癌症治疗中的作用:我们有进展吗?
Front Oncol. 2022 Mar 24;12:819128. doi: 10.3389/fonc.2022.819128. eCollection 2022.
8
Cellular model system to dissect the isoform-selectivity of Akt inhibitors.用于剖析 Akt 抑制剂的异构体选择性的细胞模型系统。
Nat Commun. 2021 Sep 6;12(1):5297. doi: 10.1038/s41467-021-25512-8.
9
Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer.针对人类癌症的靶向治疗,攻击 PI3K/Akt/mTOR 信号通路。
Semin Cancer Biol. 2022 Oct;85:69-94. doi: 10.1016/j.semcancer.2021.06.019. Epub 2021 Jun 25.
10
PI3K Inhibitors in Cancer: Clinical Implications and Adverse Effects.PI3K 抑制剂在癌症中的临床意义和不良反应。
Int J Mol Sci. 2021 Mar 27;22(7):3464. doi: 10.3390/ijms22073464.